Dialysis News and Research

Latest Dialysis News and Research

Study finds new therapeutic target for polycystic kidney disease

In work suggesting a new approach to treating polycystic kidney disease (PKD), a leading cause of kidney failure, researchers at Children's Hospital Boston were able to block the formation of fluid-filled cysts, the hallmark of the disease, in a mouse model. Their findings, using a compound that inhibits a receptor known as c-Met, will be published in the September 13th online edition of the Journal of Clinical Investigation.

14 Sep 2010

Diplomat Specialty Pharmacy ranked #554 on Inc.'s Top 5000 list of fastest-growing private companies

Diplomat Specialty Pharmacy announced today they have earned a position of 554 on Inc. Magazine's exclusive, annual ranking of the fastest-growing private companies in America.

10 Sep 2010

Aethlon Hemopurifier captures immunosuppressive exosomes from individuals with metastatic melanoma.

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that its researchers have demonstrated the ability of the Aethlon Hemopurifier® to capture immunosuppressive exosomes derived from individuals with metastatic melanoma.

9 Sep 2010

Changes in Japan's MHLW reimbursement will drive chronic dialysis catheter market

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, changes in Japan's Ministry of Health Labour and Welfare (MHLW) reimbursement, which encourage facilities to use higher-priced chronic dialysis catheters, will lead to double-digit growth in this segment over the next five years, and will support overall market revenues.

8 Sep 2010

Risk of late onset TRAS in living unrelated donor kidney recipients

Patients who have received a new kidney are significantly more likely to develop transplant renal artery stenosis (TRAS) if they are obese or over 50, according to research published in the September issue of the Journal of Renal Care.

7 Sep 2010

Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID

Celgene Corporation today announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application to the U.S. Food and Drug Administration. The application requests authorization to manufacture and market generic versions of REVLIMID (lenalidomide) 5, 10, 15 and 25 mg capsules in the United States.

3 Sep 2010

Studies show diagnostic errors cause adverse events than medication errors

Studies show that diagnostic errors cause twice as many adverse events as medication errors, but the subject has received little attention; Pennsylvania Patient Safety Authority reviews 100 events related to diagnostic error.

3 Sep 2010

Researchers unveil prototype model of first implantable artificial kidney

UCSF researchers today unveiled a prototype model of the first implantable artificial kidney, in a development that one day could eliminate the need for dialysis.

3 Sep 2010

U.S. Renal Care announces construction of new dialysis center in Oklahoma

U.S. Renal Care, Inc. (USRC), a leading privately-held provider of outpatient dialysis services, today announced it has started construction of a dialysis center in Grove, Oklahoma, the company's first in the state. The center, expected to open in December 2010, will bring the company's patient total to more than 5,500 served across 85 dialysis centers, home and specialty hospital dialysis programs and facilities. The expansion into northeast Oklahoma is part of USRC's commitment to serving rural communities without dialysis or nephrology services.

2 Sep 2010

Blood pressure treatment may prevent end-stage kidney disease in some patients: Study

Intensively treating hypertension in some African Americans with kidney disease by pushing blood pressure well below the current recommended goal may significantly decrease the number who lose kidney function and require dialysis, suggests a Johns Hopkins-led study publishing in the New England Journal of Medicine Thursday.

2 Sep 2010

Illinois profs receive grant to work with kidney dialysis patients

University of Illinois scientists will learn whether protein supplements and cycling during treatments can help dialysis patients fight cardiovascular disease and retain physical function, thanks to a $2.1 million grant from the National Institutes of Health (NIH).

2 Sep 2010

Calif. allows safety-net coverage cost increase; Georgia illegal immigrant dialysis agreement reached

"As state leaders blast giant health insurers for raising rates, Gov. Arnold Schwarzenegger's administration has quietly allowed hefty increases for thousands of sick or jobless Californians who must rely on expensive safety-net coverage -- if they want insurance at all.

2 Sep 2010

Non-kidney transplant patients likely to undergo kidney transplant prior to dialysis: Study

Kidney failure may accompany or complicate transplantation of the liver, heart, or lung. Because increasing numbers of individuals are receiving non-kidney transplants, researchers have wondered whether more of such patients are being listed for kidney transplants.

2 Sep 2010

AngioDynamics launches new access kit for VenaCure EVLT system to treat varicose veins

AngioDynamics announced today the launch of a new access kit allowing fewer procedure steps and faster procedure time for physicians using the VenaCure EVLT system's NeverTouch® gold-tip laser fiber to treat varicose veins.

30 Aug 2010

Hemoglobin variability does not increase mortality in European hemodialysis patients: Study

Fluctuations in blood composition that often arise from commonly used therapies among kidney disease patients are not an independent predictor of adverse outcomes for European hemodialysis patients, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results suggest that although hemoglobin variability is common in kidney disease patients, it does not appear to increase their likelihood of dying early.

27 Aug 2010

Aethlon Medical receives approval for Chronic HCV Infection treatment

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that the Medanta Independent Ethics Committee (MIEC) at Medanta, The Medicity Institute (Medicity) has approved a treatment program entitled "Use of the Aethlon Hemopurifier in Treating Chronic HCV Infection in Combination with Standard of Care (SOC) Drug Therapy."

26 Aug 2010

Veteran Affairs to use Redsense alarm to detect blood leakage during hemodialysis

The Redsense alarm will be required for use in Veteran Affairs' dialysis centers. The safety alert, based on research from Veteran Affairs National Center for Patient Safety, marks an important step for the only alarm that detects blood leakage during hemodialysis.

26 Aug 2010

Fresenius Medical Care inks agreement to acquire Gambro's worldwide peritoneal dialysis business

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced that it has signed an agreement to acquire Gambro's worldwide peritoneal dialysis (PD) business. Gambro has decided to prioritize its investments in the hemodialysis field. Fresenius Medical Care is taking advantage of this opportunity to expand its activities in the homecare market, especially in Europe and Asia-Pacific.

26 Aug 2010

Celgene to enforce REVLIMID intellectual property rights following receipt of Paragraph IV notification letter

Celgene Corporation today announced that information was posted on the FDA Web site indicating that an Abbreviated New Drug Application (ANDA) has been received by the Office of Generic Drugs (OGD) containing a "Paragraph IV" patent certification, for REVLIMID (lenalidomide) 25 mg capsules. Celgene has not yet received the Paragraph IV notification letter identifying the filer.

25 Aug 2010

BioTrends' online survey provides in-depth view of dialysis vascular access market

BioTrends Research Group, Inc. recently published its TreatmentTrends: Vascular Access report. This report is based on online survey results from over 150 physicians (general nephrologists, surgeons, interventional radiologists and interventional nephrologists).

25 Aug 2010

Dialysis News and Research

Latest Dialysis News and Research

Study finds new therapeutic target for polycystic kidney disease

Diplomat Specialty Pharmacy ranked #554 on Inc.'s Top 5000 list of fastest-growing private companies

Aethlon Hemopurifier captures immunosuppressive exosomes from individuals with metastatic melanoma.

Changes in Japan's MHLW reimbursement will drive chronic dialysis catheter market

Risk of late onset TRAS in living unrelated donor kidney recipients

Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID

Studies show diagnostic errors cause adverse events than medication errors

Researchers unveil prototype model of first implantable artificial kidney

U.S. Renal Care announces construction of new dialysis center in Oklahoma

Blood pressure treatment may prevent end-stage kidney disease in some patients: Study

Illinois profs receive grant to work with kidney dialysis patients

Calif. allows safety-net coverage cost increase; Georgia illegal immigrant dialysis agreement reached

Non-kidney transplant patients likely to undergo kidney transplant prior to dialysis: Study

AngioDynamics launches new access kit for VenaCure EVLT system to treat varicose veins

Hemoglobin variability does not increase mortality in European hemodialysis patients: Study

Aethlon Medical receives approval for Chronic HCV Infection treatment

Veteran Affairs to use Redsense alarm to detect blood leakage during hemodialysis

Fresenius Medical Care inks agreement to acquire Gambro's worldwide peritoneal dialysis business

Celgene to enforce REVLIMID intellectual property rights following receipt of Paragraph IV notification letter

BioTrends' online survey provides in-depth view of dialysis vascular access market

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in